Implementing the aspirin guidelines into clinical care (I-MAGIC Project)

Abstract

In 2017, Cancer Council Australia updated their guidelines for the prevention of colorectal cancer (CRC) to recommend that all people aged 50–70 who are at average risk of CRC actively consider taking aspirin to reduce their risk. Interviews were conducted with a range of health professionals whom the new guidelines may apply, including gastroenterologists, geneticists, genetic counsellors, pharmacists and general practitioners. Interviews explored their current practice, knowledge and opinions toward recommending aspirin to people at average risk of CRC and potential barriers and facilitators to implementing the guidelines. An expected frequency tree showing the potential harms and benefits of aspirin was also developed to facilitate discussion of the risks and benefits of aspirin with patients. Interviews were coded using thematic analysis and themes were mapped onto the Consolidated Framework for Implementation Research